BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.75 EUR
-0.72%
Market Closed
Updated:
May 18, 2024
BRAIN Biotech AG
Other Liabilities
|
BRAIN Biotech AG
Other Liabilities Peer Comparison
Comparables:
WCH
EVK
1COV
ACT
SY1
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BRAIN Biotech AG
XETRA:BNN
|
Other Liabilities
€32.6m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Wacker Chemie AG
XETRA:WCH
|
Other Liabilities
€1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Evonik Industries AG
XETRA:EVK
|
Other Liabilities
€2.8B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-4%
|
|
|
Covestro AG
XETRA:1COV
|
Other Liabilities
€733m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
AlzChem Group AG
XETRA:ACT
|
Other Liabilities
€120.2m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Symrise AG
XETRA:SY1
|
Other Liabilities
€535m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
See Also
What is BRAIN Biotech AG's Other Liabilities?
Other Liabilities
32.6m
EUR
32.6m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Other Liabilities amounts to 32.6m EUR.
What is BRAIN Biotech AG's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
1%
1%
Over the last year, the Other Liabilities growth was 33%. The average annual Other Liabilities growth rates for BRAIN Biotech AG have been -1% over the past three years , 1% over the past five years .
You don't have any saved screeners yet
